The increase in CCL-22 during the initial stages of inflammation is in line with the results reported by Ying et al [37] and Frankenberger et al 2011 [39] who showed a similar pattern upon LPS induced inflammation in COPD and this could help in recruitment of effector T-lymphocytes to sites of inflammation [40]. Here, CCL22 is linked to chronic obstructive pulmonary disease.